Christine Morse advises a wide range of healthcare companies on fraud and abuse claims, reimbursement issues and regulatory compliance. She has extensive experience advising provider organizations on key federal healthcare laws, such as the Stark Law, the Anti-Kickback Statute (AKS) and the False Claims Act (FCA). Christine also has deep knowledge the federal 340B Drug Pricing Program.
Christine brings her comprehensive regulatory experience to a wide range of healthcare companies, including hospitals, health systems, pharmacies, laboratories, durable medical equipment (DME) providers, home health providers, physicians and other healthcare practitioners, device manufacturers, and long-term-care providers.
Christine is experienced in conducting compliance effectiveness reviews for numerous types of organizations and providers and frequently advises clients on Office of Inspector General (OIG) and Department of Justice (DOJ) guidance on compliance programs. She has also counseled healthcare companies in numerous investigations led by federal and state law enforcement. Drawing on more than 20 years of experience with compliance matters, she has devised and implemented legal strategies for clients on all aspects of government probes, from the initial investigatory stages to settlement or litigation.
Christine also focuses her practice on counseling institutional and specialty pharmacies. She has advised pharmacies on licensure, Medicaid reimbursement and Medicare Part D issues. She also has worked extensively on issues related to participating in the 340B program for both pharmacies and covered entities such as disproportionate share hospitals (DSH) and Ryan White centers.
She also advises healthcare providers on acquisition due diligence, compliance effectiveness evaluations, and other critical matters.